Villafuerte, Julieta .

HRN: 27-87-75  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/01/2025
AZITHROMYCIN 500MG TABLET (TAB)
10/01/2025
10/05/2025
PO
500mg
OD
CAP-MR
Checking Initial Appropriateness 
10/01/2025
CEFTAZIDIME 1GM (VIAL)
10/01/2025
10/08/2025
IV
1g
Q8hr
CAP-MR
Checking Initial Appropriateness 
10/05/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
10/05/2025
10/11/2025
IVTT
4.5g
Q6
Cap-MR- Empirical Escalation
Waiting Final Action 
10/05/2025
LEVOFLOXACIN 500MG (TAB)
10/05/2025
10/09/2025
PO
500 Mg/tab, 1 Tab
Od
Cap-MR
Waiting Final Action 
10/05/2025
LEVOFLOXACIN 500MG (TAB)
10/05/2025
10/09/2025
PO
500 Mg/tab, 1 Tab
Od
Cap-MR
Waiting Final Action 
10/05/2025
LEVOFLOXACIN 500MG (TAB)
10/05/2025
10/09/2025
PO
500 Mg/tab, 1 Tab
Od
Cap-MR
Waiting Final Action 
10/05/2025
LEVOFLOXACIN 500MG (TAB)
10/05/2025
10/09/2025
PO
500 Mg/tab, 1 Tab
Od
Cap-MR
Waiting Final Action 
10/05/2025
LEVOFLOXACIN 500MG (TAB)
10/05/2025
10/09/2025
PO
500 Mg/tab, 1 Tab
Od
Cap-MR
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: